Perioperative nivolumab (NIVO) + chemotherapy (chemo) in patients (pts) with resectable early-stage non-small cell lung cancer (NSCLC): CheckMate 77T final formal overall survival (OS) analysis (ESMO-IO 2026) - Oct 25, 2026 - Abstract #276P; Pres time: Dec 14, 2026; 05:30 PM - 06:30 PM; Location: Churchill Room; No abstract available
Clinical • Lung Cancer • Non Small Cell Lung Cancer • Oncology • Solid Tumor
|
|
Mariano Pr ovencio Pulla; Mark Awad; Jonathan Spicer; Jie He; Shun Lu; Fumihiro Tanaka; Robin Cornelissen; Lubos B. Petruzelka; Jean-Louis Pujol; Hiroyuki Ito; Ludmila D. Koch; Lin Wu; Yasutaka Watanabe; Edward Ezenwafor; Lillian Tseng; Stephanie Meadows-Shropshire; Michael Antzis; David Cano Rodriguez; Tina Cascone
|